FDA Drug Approval Comes Too Late for Many Patients

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/12352782/12352783" width="100%" height="290" frameborder="0" scrolling="no">

Listen to this 'Talk of the Nation' topic

For many patients dying of cancer, their last chance at survival may not yet be an option. Experimental drugs often take years to approve, and in the testing phase they are only available to a tiny group of patients. Do patients have a constitutional right to try experimental drugs?

Frank Burroughs, president, Abigail Alliance for Better Access to Developmental Drugs

Frances Miller, professor of law, Boston University School of Law

Dr. Emil Freireich, director, Adult Leukemia Research Program, University of Texas M.D. Anderson Cancer Center

Dr. Ezekiel Emanuel, chair of the Department of Bioethics for The Clinical Center at the National Institutes of Health



Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.